Athenahealth seeks a few good innovators

Laura Pedulli | | Health Exec | Precision Medicine

Athenahealth, a provider of cloud-based services and mobile health tools, is in search of start-ups to participate in its More Disruption Please (MDP) Accelerator program.

The program provides the companies with seed funding, free office space at its Watertown, Mass. headquarters and mentorship opportunities. The program also links the portfolio companies to its network of more than 55,000 healthcare providers through its online platform. Companies interested in working with MDP can access and test athenahealth's APIs through a reimagined developer portal, designed to streamline global connectivity with athenaNet, according to a release.

The accelerator program is an extension to its pre-existing MDP network, which was formed in 2010 to bring healthcare innovators together through conference and hackathons. The athenahealth Marketplace, introduced in 2013, integrates new technologies into athenahealth's cloud-based network to offer complementary services that enhance athenaNet. The accelerator is the third component of the MDP program.

The accelerator program is accepting applications on a rolling basis, with an anticipated residency period of eight to 12 months for each portfolio company.

More information is here.

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.